Clinical Trial Update: Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial update of OPC-34712 evaluating safety in adults with normal renal function and renal impairment, including subjects with schizophrenia; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• OPC-34712

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia, Psychiatric Disorders | Phase 1 | Status: COMPLETED | Results posted: 2015-10-29